Results 171 to 180 of about 3,550,191 (258)

Dual‐Functional Silent‐Region SERS Nanoplatform for Real‐Time Bacterial Tracking and Wound Healing Therapy

Advanced Science, EarlyView.
ABSTRACT Bacterial wound infections, particularly those caused by Escherichia coli and Pseudomonas aeruginosa, are difficult to treat due to biofilm formation, multidrug resistance, and chronic inflammation. Here, we report a multifunctional nanoplatform based on a surface‐enhanced Raman scattering (SERS) probe that enables simultaneous photodynamic ...
Hanbin Deng, Rui Wang, Dianqi Zhang, Wei Zhang, Jaebum Choo, Fabiao Yu, Shaowen Cheng   +6 more
wiley   +1 more source

Enhancing mass vaccination programs with queueing theory and spatial optimization. [PDF]

Front Public Health
Xie S, Rieders M, Changolkar S, Bhattacharya BB, Diaz EW, Levy MZ, Castillo-Neyra R.   +6 more
europepmc   +1 more source

Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity. [PDF]

Chin Med J (Engl), 2023
Bao P, Gong J, Mu M, Que Y, Hu P, Luo J, Chang C, Xu G.   +7 more
europepmc   +1 more source

Histone H3K18 Lactylation Promotes the Malignant Progression of Wilms Tumor via a PSRC1/AKT/HIF‐1α Positive Feedback Loop

Advanced Science, EarlyView.
In nephroblastoma, aberrant glycolysis drives lactate accumulation, which elevates histone H3K18 lactylation via p300. Lactylation of the PSRC1 promoter activates its transcription. PSRC1 competitively binds AKT, relieving PTEN‐mediated inhibition and triggering AKT/mTOR/HIF‐1α signaling.
Yanping Wang, Hongjie Gao, Bifei Zhang, Xuetian Li, Ding Li, Aihua Cao, Fengyin Sun   +6 more
wiley   +1 more source

Assessing the feasibility of partner-implemented digital payment systems for health workers: stakeholder perspectives from Uganda's yellow fever mass vaccination campaign - a qualitative study. [PDF]

BMJ Glob Health
Ediau M, Ekirapa Kiracho E, Aweko J, Opio C, Ashaba MS, Waiswa P.   +5 more
europepmc   +1 more source

Why does COVID-19 continue to spread despite mass vaccination? [PDF]

Front Public Health, 2022
Zhang S, Yang Z, Chen ZL, Yue SJ, Zhang S, Tang YP.   +5 more
europepmc   +1 more source

Probiotic‐Derived Vesicles Rectally Delivered via Thermo‐Gelling Copolymer Promote Mucosal Healing and Reduce Inflammation in Ulcerative Colitis

Advanced Science, EarlyView.
A thermo‐responsive rectal delivery platform integrating probiotic‐derived extracellular vesicles within a hyaluronic acid‐based copolymer enables localized and sustained therapy for ulcerative colitis. The formulation effectively suppresses inflammation, promotes macrophage polarization toward a regenerative phenotype, restores epithelial barrier ...
Ayushi Mairal, Ubaid Tariq, Shreya Mehrotra, Saravanan Matheshwaran, Jan Marsal, Ashok Kumar   +5 more
wiley   +1 more source

Developing a Roadmap for Mass Vaccination of COVID-19 in Iran: A Qualitative Study. [PDF]

Disaster Med Public Health Prep, 2022
Seyedin H, Dowlati M, Barzegar M, Bahramzadeh S, Khanizade A, Roshanravan M, Adibi H, Barghi-Shirazi F, Rouhollahi M.   +8 more
europepmc   +1 more source

Hollow Cu2O Nanozymes Enhance Probiotic Therapy for Colitis via Redox Homeostasis and TXNIP/NLRP3 Inflammasome Inhibition

Advanced Science, EarlyView.
Hollow cuprous oxide (H‐Cu2O) nanozymes feature enlarged catalytic surfaces for superior reactive oxygen species (ROS) scavenging. By efficiently neutralizing mucosal ROS, H‐Cu2O directly suppresses the TXNIP/NLRP3 inflammasome axis and restores intestinal epithelial barrier integrity.
Guangzhao Wang, Jialing Cao, Pengfei Li, Yujie Wang, Shiqi Lu, Kangliang Sheng, Shan Gao, Yongzhong Wang   +7 more
wiley   +1 more source

Characterization of Conserved Evolution in H7N9 Avian Influenza Virus Prior Mass Vaccination. [PDF]

Virulence
He D, Wang X, Wu H, Cai K, Song X, Wang X, Hu J, Hu S, Liu X, Ding C, Peng D, Su S, Gu M, Liu X.   +13 more
europepmc   +1 more source